You are here

AusPAR: Buprenorphine

Related information


How to access a pdf or Word document

*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.

Australian Public Assessment Report

18 November 2019
AusPAR Details
AusPAR
Active Ingredient
Buprenorphine
Product Name
Buvidal
Sponsor
Camurus Pty Ltd
Submission Number
PM 2017-02926-1-1
Submission Type
Major variation (new dose form and new dose strengths)
Decision
Approved
AusPAR Date
6 November 2019
Publication Date

18 November 2019